1. Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells
- Author
-
D. Proverbio, T. Kralj, Madelon M. Maurice, Piet Gros, Sarah Stryeck, M. Goldflam, C. Ullman, G. Hermans, T. Aastrup, R.C. van Scherpenzeel, T.Z. Bass, Ingrid Jordens, and Nicola Fenderico
- Subjects
Models, Molecular ,0301 basic medicine ,Transcription, Genetic ,Protein Conformation ,Receptor expression ,Cellular differentiation ,General Physics and Astronomy ,02 engineering and technology ,Crystallography, X-Ray ,Mice ,Models ,Intestine, Small ,Stem Cells/cytology ,Low Density Lipoprotein Receptor-Related Protein-5/antagonists & inhibitors ,lcsh:Science ,Non-U.S. Gov't ,beta Catenin ,Tissue homeostasis ,Tumor ,Crystallography ,Multidisciplinary ,Chemistry ,Research Support, Non-U.S. Gov't ,Stem Cells ,Wnt signaling pathway ,LRP6 ,Cell Differentiation ,LRP5 ,Wnt3A Protein/genetics ,021001 nanoscience & nanotechnology ,Intestine ,3. Good health ,Cell biology ,Organoids ,Low Density Lipoprotein Receptor-Related Protein-5 ,Low Density Lipoprotein Receptor-Related Protein-6 ,Organoids/cytology ,Stem cell ,0210 nano-technology ,Transcription ,Protein Binding ,Single-Domain Antibodies/chemistry ,Intestine, Small/cytology ,beta Catenin/genetics ,Ubiquitin-Protein Ligases ,Science ,Research Support ,Article ,General Biochemistry, Genetics and Molecular Biology ,Cell Line ,03 medical and health sciences ,Low Density Lipoprotein Receptor-Related Protein-6/antagonists & inhibitors ,Genetic ,Cell Line, Tumor ,Wnt3A Protein ,Small/cytology ,Journal Article ,Animals ,Humans ,Protein Interaction Domains and Motifs ,Ubiquitin-Protein Ligases/genetics ,Cell Proliferation ,Binding Sites ,HEK 293 cells ,Molecular ,General Chemistry ,Fibroblasts ,Single-Domain Antibodies ,HEK293 Cells ,030104 developmental biology ,Fibroblasts/cytology ,Gene Expression Regulation ,X-Ray ,lcsh:Q ,Protein Conformation, beta-Strand ,beta-Strand - Abstract
Wnt-induced β-catenin-mediated transcription is a driving force for stem cell self-renewal during adult tissue homeostasis. Enhanced Wnt receptor expression due to mutational inactivation of the ubiquitin ligases RNF43/ZNRF3 recently emerged as a leading cause for cancer development. Consequently, targeting canonical Wnt receptors such as LRP5/6 holds great promise for treatment of such cancer subsets. Here, we employ CIS display technology to identify single-domain antibody fragments (VHH) that bind the LRP6 P3E3P4E4 region with nanomolar affinity and strongly inhibit Wnt3/3a-induced β-catenin-mediated transcription in cells, while leaving Wnt1 responses unaffected. Structural analysis reveal that individual VHHs variably employ divergent antigen-binding regions to bind a similar surface in the third β-propeller of LRP5/6, sterically interfering with Wnt3/3a binding. Importantly, anti-LRP5/6 VHHs block the growth of Wnt-hypersensitive Rnf43/Znrf3-mutant intestinal organoids through stem cell exhaustion and collective terminal differentiation. Thus, VHH-mediated targeting of LRP5/6 provides a promising differentiation-inducing strategy for treatment of Wnt-hypersensitive tumors., Enhanced Wnt receptor activity is a major cause of cancer development. Here the authors identify camelid single-domain antibody fragments (VHHs) that bind to the Wnt receptor LRP5/6 ectodomain, determine the crystal structures and show that these VHHs selectively inhibit Wnt3- mediated cellular responses and block the growth of mutant Wnt-hypersensitive intestinal tumor organoids.
- Published
- 2019